Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

about

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

Item

http://www.wikidata.org/entity/Q55280841

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

@en

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

@nl

type

Item

label

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

@en

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

@nl

prefLabel

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

@en

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

@nl

P1476

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

@en

P2093

John J Lima

http://www.w3.org/2001/XMLSchema#string

Julie A Johnson

http://www.w3.org/2001/XMLSchema#string

Nihal El Rouby

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenomics knowledge for personalized medicine

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

Pharmacology of proton pump inhibitors

The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

Pharmacogenetics, drug-metabolizing enzymes, and clinical practice

Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis

The pharmacology of the gastric acid pump: the H+,K+ ATPase

Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype

P304

447-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/17425255.2018.1461835

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29620484

http://www.w3.org/2001/XMLSchema#string

P921

P932

5942154

http://www.w3.org/2001/XMLSchema#string